Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruitao Lin

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Statistical Methods in Medical Research|April 4, 2024
A Bayesian quasi-likelihood design for identifying the minimum effective dose and maximum utility dose in dose-ranging studiesFeng Tian, Ruitao Lin, Li Wang, et al.
Statistics in Biopharmaceutical Research|September 20, 2024
Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple EndpointsGuillaume Mulier, Sylvie Chevret, Ruitao Lin, et al.
International Journal of Epidemiology|May 20, 2025
Sample-size determination for decentralized clinical trialsFeng Tian, Ruitao Lin, Suyu Liu, et al.
Statistics in Biopharmaceutical Research|May 5, 2025
Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination TrialsMengyi Lu, Jingyi Zhang, Ying Yuan, et al.
Statistics in Medicine|March 2, 2021
uTPI: A utility-based toxicity probability interval design for phase I/II dose-finding trialsHaolun Shi, Jiguo Cao, Ying Yuan, et al.
Clinical Trials (London, England)|January 20, 2024
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific dosesJingyi Zhang, Ruitao Lin, Xin Chen, et al.
Pharmaceutical Statistics|August 14, 2025
Drift Parameter Based Sample Size Determination in Multi-Stage Bayesian Randomized Clinical TrialsYueyang Han, Haolun Shi, Jiguo Cao, et al.
Statistical Methods in Medical Research|August 18, 2023
Local continual reassessment methods for dose finding and optimization in drug-combination trialsJingyi Zhang, Fangrong Yan, Nolan A Wages, et al.
Clinical Trials (London, England)|May 30, 2026
Phase I design for partially ordered groups with late-onset toxicityRami Hawila, Susan Halabi, Ruitao Lin, et al.
Statistics in Medicine|May 17, 2026
Two-Stage Double-Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical RegionJiashan He, Ruitao Lin, Yaxian Chen, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Statistical Methods in Medical Research|April 4, 2024
A Bayesian quasi-likelihood design for identifying the minimum effective dose and maximum utility dose in dose-ranging studiesFeng Tian, Ruitao Lin, Li Wang, et al.
Statistics in Biopharmaceutical Research|September 20, 2024
Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple EndpointsGuillaume Mulier, Sylvie Chevret, Ruitao Lin, et al.
International Journal of Epidemiology|May 20, 2025
Sample-size determination for decentralized clinical trialsFeng Tian, Ruitao Lin, Suyu Liu, et al.
Statistics in Biopharmaceutical Research|May 5, 2025
Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination TrialsMengyi Lu, Jingyi Zhang, Ying Yuan, et al.
Statistics in Medicine|March 2, 2021
uTPI: A utility-based toxicity probability interval design for phase I/II dose-finding trialsHaolun Shi, Jiguo Cao, Ying Yuan, et al.
Clinical Trials (London, England)|January 20, 2024
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific dosesJingyi Zhang, Ruitao Lin, Xin Chen, et al.
Pharmaceutical Statistics|August 14, 2025
Drift Parameter Based Sample Size Determination in Multi-Stage Bayesian Randomized Clinical TrialsYueyang Han, Haolun Shi, Jiguo Cao, et al.
Statistical Methods in Medical Research|August 18, 2023
Local continual reassessment methods for dose finding and optimization in drug-combination trialsJingyi Zhang, Fangrong Yan, Nolan A Wages, et al.
Clinical Trials (London, England)|May 30, 2026
Phase I design for partially ordered groups with late-onset toxicityRami Hawila, Susan Halabi, Ruitao Lin, et al.
Statistics in Medicine|May 17, 2026
Two-Stage Double-Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical RegionJiashan He, Ruitao Lin, Yaxian Chen, et al.
Pageof 10